NCT02778126View on ClinicalTrials.gov

A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 22, 2016

Primary Completion Date

April 29, 2017

Study Completion Date

July 27, 2017

Conditions
Advanced Cancer
Interventions
DRUG

[¹⁴C]Prexasertib

Administered IV Infusion

DRUG

Prexasertib

Administered IV Infusion

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Liverpool

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02778126 - A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer | Biotech Hunter | Biotech Hunter